Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
•
Male Breast Cancer
Is it reasonable to use hypofractionation in early stage male breast cancer s/p lumpectomy?
What clinical and pathologic features - if any - would necessitate conventional fractionation?
Answer from: Radiation Oncologist at Community Practice
Absolutely the same as what we do for women with breast cancer.
Comments
Radiation Oncologist at Allegheny Health Network, Pittsburgh
Agreed, while we don't have an RCT for male breast...
Radiation Oncologist at SSM Cancer Center/St Louis CyberKnife
Taking this question further, can we assume that p...
6090
15916
Sign in or Register to read more
12580
Related Questions
Would you feel comfortable doing high tangents with ultra-hypofractionation?
How would you manage a patient with micrometastatic node positive tumor post mastectomy (no neoadjuvant chemotherapy)?
How would you treat a young breast cancer patient with limited nodal involvement and an isolated sternal oligometastasis at diagnosis?
Are you comfortable combining palliative radiotherapy with capivasertib/fulvestrant?
Is 5fx APBI and no endocrine therapy a new standard of care for women over 70 years old with low-risk breast cancer given the interim analysis of the EUROPA trial?
Should PMRT be offered for ypN0(i+) disease if only 1-2 nodes were removed in the post-chemotherapy SLNB and there is no plan for a completion AxLND?
In patients with HER-2 positive breast cancer on pertuzumab/trastuzumab with newly developed asymptomatic brain metastases only, do you wait 3 weeks after administration of the targeted therapy to deliver SRS?
Would you offer ultrahypofractionated 5-fraction whole breast only for a women with ER-/HER2+/cN+ disease with pCR following neoadjuvant systemic therapy?
What are your top takeaways in Breast Cancer from ESMO 2024?
For a young female (<40) with HR-/HER2+ cT1-2N1, ypT1aN0 s/p mastectomy with SLNB, would you offer PMRT?
Agreed, while we don't have an RCT for male breast...
Taking this question further, can we assume that p...